| (1) Cystic fibrosis — the disease
The incidence of cystic fibrosis is one in 3,500 live,
white births, making it the most prevalent fatal, recessive genetic disease
among Caucasians. This, the first in a series of three articles intended
to mark National Cystic Fibrosis Week (March 31 to April 8), describes
the disease and the systems that it affects
(PDF 130K)
Pharmaceutical Journal, 31 March 2001, p423-424. Vol 266, no 7141
|
| (2) Treating children with cystic fibrosis
In the second of a series of three articles on cystic
fibrosis, the treatment of children with the condition is discussed
(PDF 130K)
Pharmaceutical Journal, 7 April 2001, p468-472. Vol 266, no7142
|
| (3) Treating adults with cystic fibrosis
The final article in this series describes some of the
drug treatments that are available to adult patients with cystic fibrosis
(PDF 110K)
Pharmaceutical Journal, 14 April 2001, p508-510. Vol 266, no7143
|
|
|
• Most photographs have been removed from
the PDF files for copyright reasons.
• The contents of the Pharmaceutical Journal, associated publications
and all PDF files are the property of the Royal Pharmaceutical Society. See Copyright for
our rights.
|
|
Photocopies
Photocopies of articles can be ordered from the Society’s
library (library@rpsgb.org.uk);
for details click here
|
|
Reprints
Details on multiple reprints of the original articles are here
|
|
